Answers are grounded in this paper and cite their sources.
Nonhuman primate study reveals natural killer cell subsets associated with viral control in macaques, indicating the NKG2A axis supports durable post-treatment remission.
Post-treatment HIV controllers (PTC) offer a unique opportunity to uncover the determinants of durable remission after antiretroviral therapy (ART) interruption. Here, using six PTC and six post-treatment non-controllers from the pVISCONTI study in cynomolgus macaques, we identify associations between Natural Killer (NK) cell subsets and outcomes following ART interruption. NKG2Ahigh NK cells lacking NKp30/NKp46 (NKG2AhighNKp30-NKp46-), shaped by the MHC backgrounds of the animals, were linked to improved post-treatment control; this NK subset displayed tissue-homing potential and preserved functionality despite infection, characterized by cytokine production and degranulation. Conversely, NKG2AlowNKp30 + NKp46+ NK cells exhibited reduced cytotoxic potential and elevated IL-10/IL-17A production, and their pre-infection levels were associated with higher viremia and larger viral reservoirs after ART interruption. Our study suggests that constitutive NK cell features, preserved by early ART initiation, may provide a favorable immune environment for post-treatment control. Our findings identify the NKG2A axis as a potential target to improve outcomes after ART interruption
No takes yet. Share an insight, caveat, or question.
Chapel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: